Inosine pranobex

DRUG7 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Newport Pharmaceuticals International

Conditions

HIV InfectionsLymphatic Disease

Phase 1

A Phase I/II Trial of Ribavirin (With Escalation) + Isoprinosine in Asymptomatic HIV-Viremic Patients

CompletedNCT00000699

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

Target: 20Updated: 2008-08-26

Unknown Phase

A Study of Isoprinosine in Patients With Lymph Node Disease

CompletedNCT00002297

Newport Pharmaceuticals InternationalHIV Infections, Lymphatic Disease

Updated: 2005-06-24

A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Immunodepressed Patients With Uncomplicated Generalized Lymphadenopathy

CompletedNCT00002061

Newport Pharmaceuticals InternationalHIV Infections, Lymphatic Disease

Updated: 2005-06-24

A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Patients With AIDS Related Complex (ARC)

CompletedNCT00002060

Newport Pharmaceuticals InternationalHIV Infections

Updated: 2005-06-24

The Safety and Effectiveness of Isoprinosine in Patients With Weakened Immune Systems and Lymph Node Disease

CompletedNCT00002296

Newport Pharmaceuticals InternationalHIV Infections, Lymphatic Disease

Updated: 2005-06-24

A Double-Blind Placebo Controlled Study To Determine the Optimal Immunopharmacological Dose Level of Isoprinosine in Immunodepressed Volunteers

CompletedNCT00002059

Newport Pharmaceuticals InternationalHIV Infections

Updated: 2005-06-24

A Study of Isoprinosine in Patients With Severe AIDS

CompletedNCT00002295

Newport Pharmaceuticals InternationalHIV Infections

Updated: 2005-06-24